A new warning from UNAIDS signals that HIV prevention and treatment services are deteriorating globally, raising concerns about reversals in decades of progress against the pandemic. The agency’s assessment reflects growing gaps in access to antiretroviral therapy, pre-exposure prophylaxis (PrEP), and other critical interventions, particularly in low- and middle-income countries where the burden of disease remains heaviest.
Global HIV Service Coverage and Access Barriers
| Service Type | Status Assessment | Primary Challenge |
|---|---|---|
| Antiretroviral Therapy (ART) | Uneven access by region | Funding gaps and supply chain disruption |
| Pre-Exposure Prophylaxis (PrEP) | Limited availability | High cost and limited awareness |
| HIV Testing Services | Coverage declining | Reduced public health investment |
| Sexual Health Services | Fragmented delivery | Stigma and resource constraints |
Source: UNAIDS, 2026
## Treatment Access Under Pressure
Access to antiretroviral treatment remains unequally distributed across regions, with sub-Saharan Africa accounting for the majority of HIV-positive individuals but facing persistent supply and funding challenges. UNAIDS has documented that while treatment initiation remains critical, adherence support and continuous access are increasingly compromised by economic pressures on national health systems. The interruption of treatment regimens poses a direct risk to individual health outcomes and fuels the emergence of drug-resistant HIV strains, a concern underscored in recent research published in The Lancet.
## Prevention Programmes Retreat
Prevention services—including harm reduction for people who inject drugs, sexual health education, and PrEP provision—have contracted in many settings due to reduced government allocation and donor fatigue. UNAIDS emphasizes that the scale-up of PrEP, a highly effective prevention tool, has stalled in regions where it is most needed, particularly among key populations including men who have sex with men, sex workers, and transgender individuals. Stigma, regulatory barriers, and pricing mechanisms continue to limit uptake in communities where HIV incidence remains elevated.
## Testing and Diagnosis: The Broken Chain
The diagnostic foundation of HIV response—reliable, accessible testing—is deteriorating. Many countries have reduced investment in community-based testing programmes and mobile clinics that historically served marginalized populations with high prevalence. Early diagnosis remains essential for infectious disease control, yet barriers to confidential, free testing are mounting. Without timely detection, individuals progress to advanced immunosuppression, increasing transmission risk and mortality.
“HIV prevention and treatment services are faltering at a critical moment when sustained investment and innovation are needed to end AIDS as a public health threat,” warns UNAIDS. The agency stress that reversals in service coverage risk undoing progress and enabling resurgence of infections in high-burden regions.
— UNAIDS, 2026
## The Road Forward
Reversal of these trends will require renewed political commitment, domestic resource mobilization, and international support. World Health Organization guidelines emphasize the importance of integrated HIV services and community engagement as cost-effective approaches. Donor countries and international financing institutions must prioritize HIV funding alongside broader global health security initiatives. National governments are urged to embed HIV services within primary healthcare systems to improve sustainability and equitable access.
Key takeaways
- UNAIDS reports that HIV prevention and treatment service capacity is declining globally, reversing decades of progress
- Antiretroviral therapy access remains unequally distributed, with sub-Saharan Africa facing supply and funding constraints
- Prevention programmes including PrEP and testing services have contracted due to reduced government and donor investment
- Renewed political commitment and domestic resource mobilization are essential to restore service coverage and prevent HIV resurgence
Frequently asked questions
Why are HIV prevention and treatment services faltering?
Services are declining due to reduced government budgets, donor fatigue, supply chain disruptions, and competition for health resources following the COVID-19 pandemic. Many national health systems have deprioritized HIV programmes in favour of other health emergencies, leading to gaps in testing, treatment initiation, and adherence support.
What is PrEP and why is access important?
Pre-exposure prophylaxis (PrEP) is a preventive medication taken by HIV-negative individuals at risk of infection, with efficacy exceeding 90% when taken consistently. Expanding PrEP access among key populations—men who have sex with men, sex workers, and people who inject drugs—is a critical prevention strategy, yet uptake remains limited by cost, stigma, and regulatory barriers in many regions.
How does HIV drug resistance emerge and why does it matter?
Drug-resistant HIV develops when individuals take incomplete courses of antiretroviral therapy or when treatment is interrupted, allowing the virus to mutate and evade medication. Resistance increases mortality risk for the individual and complicates transmission control efforts, making uninterrupted, universal access to treatment essential for public health.
Countries and international partners must act urgently to stabilize HIV services and prevent a humanitarian reversal. Without immediate investment in treatment accessibility, prevention infrastructure, and health workforce capacity, the global HIV response risks losing the gains achieved over the past three decades, with devastating consequences for millions of people living with and at risk of HIV infection.
Source: HIV prevention and treatment services faltering, warns UNAIDS
